Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

COVID-19 - Neuropilin-1, the New Doorway for Viral Entry | Lets Pharmonize Nov 17, 2021

Show notes

The additional receptor implicated in Sars-COV-2's entry process, while not exactly new, is definitely not getting the fair share of the spotlight with ACE2. Involved in many complicated pathways in normal physiology, new research points to interesting possibilities for the future of pain treatment. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane, Mickey, Cal and Justin are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health. A special thanks to Kelly Kerr for creating the music used in the intro and outro. Additional Music from Pixabay and Fesliyan Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

Intuitive Eating: Health at Every Size | Pharmacy Crossroads Nov 17, 2021

Show notes

As pharmacy expands to include more healthcare services many of them are branching off into diet, nutrition and weight loss programs. As they do this it may be prudent for them to dig a bit deeper than the traditional thinking about calorie counting and the BMI index. Linda Tucker, an independent health counselor shares some ideas on rapidly expanding ideas pharmacy owners should know about. In this episode Tucker shares her reasons why she feels trying to help patient improve their health should include learning about the Heath at Every Size and Intuitive eating movements. Whether you agree or disagree, millions of Americans are involved and as a healthcare professional she feels every pharmacist should at least be aware of them. Learn more about your ad choices. Visit megaphone.fm/adchoices

Healthcare Professional Entrepreneurship and Advocating for the Underserved with Dr. Jay Joshi | The Public Health Pharmacist Nov 16, 2021

Show notes

What does public health mean to you? Public health is the intersection where individual patient decisions meet public policy, where medicine meets law. Bio Output Medical was founded by Dr. Jay K Joshi as an Intern managing complex Intensive Care Unit (ICU) patients. Concerned by the limitations of manual urine output measurements and subsequent kidney care management, he set out to develop a technology that would improve the measuring and recording of urine output to help patients with kidney injury or kidney failure. Born out of a need to improve urine output measurements, Output Medical is passionate about kidney management and saving patient lives. Abnormally low urine output (known as oliguria) is a leading indicator of acute kidney injury (AKI) among ICU patients. AKI is a rapid and dangerous loss of kidney function which seriously impacts a patient's quality of care: it increases mortality, cost of care, length of stay, and readmission. AKI occurs in 20% of all ICU admissions each year, meaning approximately two million patients in the U.S. for whom regular and automatic urine output monitoring could improve their health. The average additional cost of a patient with AKI is nearly $16,000, a significant cost to patients and hospitals. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacogenomics and Provider Status with Scott Knoer | PGX for Pharmacists Nov 15, 2021

Show notes

According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacists. So why is that important when it comes to PGx as this is a PGx podcast? Pharmacists can order the PGx test when they see fit for their patients without the need of a clinician to sign that form. Scott Knoer, MS, PharmD, FASHP, became the 13th Executive Vice President and Chief Executive Officer of the American Pharmacists Association in June 2020, after serving for nine years as the Chief Pharmacy Officer at the Cleveland Clinic. Dr. Knoer is a passionate advocate for patients and the profession of pharmacy. He has successfully lobbied boards of pharmacy in Ohio and Minnesota to allow the advancement of pharmacy practice, and he has led initiatives that changed Ohio and federal law related to the elevation of pharmacy practice and reducing the impact of drug shortages. He received his BA in psychology from Creighton University and his PharmD from the University of Nebraska. Learn more about your ad choices. Visit megaphone.fm/adchoices

Right to Therapeutic Choice | DarshanTalks Nov 13, 2021

Show notes

In this episode of DarshanTalks Podcast, the host Darshan Kulkarni Pharm.D, MS, Esq. and Guest Speaker Lewis A. Grossman discuss the Right to Therapeutic Choice. Lewis A. Grossman's recently launched book "Choose Your Medicine: Freedom of Therapeutic Choice in America" on the freedom of medicine in the USA. Lewis Grossman, Author, Counsel at Covington & Burling LLP (https://www.cov.com/) and Professor of Law at American University, Washington College of Law, had spoken about government interference in the 19th century on the healthcare industry. The conversation started off with the expert explaining his newly launched book based on freedom of therapeutic choices in America that is affected in American law and policy. The compelled speech doctrine sets out the principle that the government cannot force an individual or group to support certain expressions, this was discussed with compelled action which initially the host gave an example of how cigarette advertisements portray and mention that cigarettes are injurious to health whilst asking the expert to share his insights over this topic. He explains his constitutional law perspective on this subject that what government can make you do and what it cannot, he also mentioned about commercial speech is not protected as supposed to political speech or artistic speech. The conversation also included an interesting topic of off-labeling drugs and ancient drugs like hydroxychloroquine and ivermectin used to treat Covid-19. Furthermore, if the branded company would have endorsed or used these drugs the implications are discussed in this podcast. Also, the subject of monoclonal antibodies was discussed, monoclonal antibodies are proteins created in a lab. The proteins mimic your immune system and are meant to make COVID-19 disease milder in patients who are already sick. As per the expert, the monoclonal antibodies are disseminated by EUA and not FDA approved, highly expensive. They talked about the history of sciences, pharma history, and much more differentiating with the bio-hacking, monoclonal antibodies, hydroxychloroquine, and ivermectin being in the same spectrum. In the mid-segment, what constitutes to be bad-advertisements and how the FDA now is disseminating about bad-ad to the medical industry. Previous Podcast with Lewis A. Grossman: https://www.youtube.com/watch?v=rTRKF... Connect with Lewis A. Grossman: On LinkedIn: https://www.linkedin.com/in/lewis-a-g... Email: lewisg@wcl.american.edu Lewis A. Grossman book link: https://global.oup.com/academic/produ... https://www.amazon.com/dp/0190612754/... Connect with us: Website: http://www.darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Twitter: https://twitter.com/darshantalks ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice. 5. This does not create an attorney-client relationship. Learn more about your ad choices. Visit megaphone.fm/adchoices

Drug Shortage Management and Supply Chain Solutions | Pharmacy Talk with IBM Watson Health Nov 12, 2021

Show notes

Join the Pharmacy Podcast Network and IBM Watson Health for another podcast episode focused on how to improve efficiencies across your organizations’ drug shortage management and supply chain. Listen to three experts discuss: - Drug shortage management and prevention – from classification and communication to key stakeholders to how COVID-19 has impacted hospital drug shortages - The role of technology & data in assisting pharmacists in solving these inventory and management challenges - How automation and emerging technology can help pharmacists provide the best care for their patients OrbitalRX, now with IBM Micromedex, combines real-time inventory awareness and clinical decision support capabilities to help hospital pharmacies proactively manage drug shortages and efficiently identify effective alternatives. View the latest evidence-based treatment information, check your hospital’s current drug inventory status, and provide purchasers with a consolidated view of procurement options – all within a single solution. Learn more here: https://www.ibm.com/products/orbitalrx Guests: - Nate Peaty, PharmD, MS, Chief Strategy Officer and Co-founder | OrbitalRX - Brian Spoelhof, PharmD, Assistant Manager of Pharmacy - Medication Utilization Strategy | University of Virginia - Chris Virgilio, PharmD, BCPS Clinical Program Director, Micromedex | IBM Watson Health Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA’s Attack on Compounding Pharmacy | Pharmacy Podcast Nation Nov 11, 2021

Show notes

In the past couple of decades compounding pharmacies have been under attack by the FDA. The FDA and compounding pharmacies are supposed to be separated unless the medications that compounding pharmacies are using are found to put the public at risk. Drug companies can only produce medications if allowed by the FDA after they have supplied years of work and evidence proving that the drug is effective and safe. In this way the FDA’s job is clear and very important. The beauty of compounding is that it’s not limited to studies here in the United States. Many compounds are based off of old medications and combinations that have simply been “grandfathered” and do not have any profit benefit for large pharmaceutical companies. Other compounds are based off of other studies that have not been submitted to the FDA and other studies are from other parts of the world, like Europe. By no means are the treatments we use in compounding pharmacies snake oil or hocus pocus. The compounding of medications is an age-old art dating back as far as the ancient Egyptians. A compounding pharmacist uses raw chemicals, powders and special equipment to make medications. This results in a customized medication made by a pharmacist according to a doctor’s directions to meet an individual patient need. References from: https://mixturesrx.com/ Guests info: Scott Brunner, CAE | Chief Executive Officer Alliance for Pharmacy Compounding (Formerly IACP) Alexandria, Virginia a4pc.org Jim Hrncir RPh Las Colinas Pharmacy Compounding & Wellness 6420 N. MacArthur Blvd, Ste 100, Irving, TX 75039 www.lascolinaspharmacy.com PCAB/ACHC Accredited Learn more about your ad choices. Visit megaphone.fm/adchoices

NCAP Pharmacy JEOPARDY! State Championship | Lets Pharmonize Nov 10, 2021

Show notes

The final installment of a series of pharmacy JEOPARDY! games, this episode features the terrific students from each of the four North Carolina Pharmacy Schools. We hope you enjoy the fun and interesting questions that explore pharmacy, chemistry, biology and more. Cheer on your champions and we'll see you at the state championship in October! This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane, Mickey, Cal and Justin are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health. A special thanks to Kelly Kerr for creating the music used in the intro and outro. Learn more about your ad choices. Visit megaphone.fm/adchoices

Show Them the Money | PGX for Pharmacists Nov 10, 2021

Show notes

Pharmacogenomics Market Access and Reimbursement Series Episode Description: Most of us understand that the reimbursement for pharmacogenomics tests has been one barrier amongst many barriers to pharmacogenomics’ wide-scale clinical adoption. Finding myself highly frustrated with the slow clinical uptake by PGx test ordering by healthcare providers back in 2017, I brainstormed about which payers were the most vested in improving patients’ medication outcomes and who would therefore more likely to listen to my pitch about PGX decreasing adverse drug events and increasing therapeutic medication outcomes. As a consultant to self-insured employers who were seeking to lower their employees’ drug spend, I found a warm and receptive audience for pharmacogenomics. It was through my relationships with self-insured employers that I met today’s guest. Again, fate intervened, and today’s guest reached out to me via LinkedIn. She had been following my pharmacogenomics posts and liking what she had seen she introduced me to a group of pharmacists in Kentucky who were integrating PGx into their PBM via comprehensive medication management. Special Guest Jane Cheshire Gilbert, CPA Jane Cheshire Gilbert, CPA Director of Retiree Health Care for the Teachers’ Retirement System of the State of Kentucky Jane has served TRS retirees since April 2002. She manages two retiree health plans covering 48,000 retirees. She also serves as a leader in the areas of health insurance cost containment, project management, risk management and federal health care solutions. Gilbert served in management and directorship positions for a Louisville, Kentucky law firm and a cost containment company, The Rawlings Company, from 1989 through 2002. Prior to that, she worked as an accountant for a national CPA firm. Gilbert earned a bachelor’s degree in accounting from Bellarmine University in Louisville, Kentucky and is a certified public accountant and a certified government benefits administrator. She has served on the board of the State and Local Government Benefits Association and is a member of the Public Sector Healthcare Roundtable. Learn more about your ad choices. Visit megaphone.fm/adchoices

Becoming a Pharmacy Badass with Lisa Faast | DiversifyRx Nov 09, 2021

Show notes

Owning a pharmacy is tougher than ever, and yet there is a ton of opportunity too. To survive and thrive, you must diversify your revenue streams and optimize your entire pharmacy. On Becoming A Pharmacy Podcast, Dr. Lisa Faast will take you through numerous strategies from the 6 Pillars of Pharmacy Profitability to help you create the pharmacy of your dreams. Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts